JP2012180344A5 - - Google Patents

Download PDF

Info

Publication number
JP2012180344A5
JP2012180344A5 JP2012023811A JP2012023811A JP2012180344A5 JP 2012180344 A5 JP2012180344 A5 JP 2012180344A5 JP 2012023811 A JP2012023811 A JP 2012023811A JP 2012023811 A JP2012023811 A JP 2012023811A JP 2012180344 A5 JP2012180344 A5 JP 2012180344A5
Authority
JP
Japan
Prior art keywords
alkyl
membered
haloalkyl
membered heterocyclyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012023811A
Other languages
English (en)
Japanese (ja)
Other versions
JP5620417B2 (ja
JP2012180344A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012023811A priority Critical patent/JP5620417B2/ja
Priority claimed from JP2012023811A external-priority patent/JP5620417B2/ja
Publication of JP2012180344A publication Critical patent/JP2012180344A/ja
Publication of JP2012180344A5 publication Critical patent/JP2012180344A5/ja
Application granted granted Critical
Publication of JP5620417B2 publication Critical patent/JP5620417B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012023811A 2011-02-07 2012-02-07 アミノピラゾール誘導体を含む医薬 Expired - Fee Related JP5620417B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012023811A JP5620417B2 (ja) 2011-02-07 2012-02-07 アミノピラゾール誘導体を含む医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011024078 2011-02-07
JP2011024078 2011-02-07
JP2012023811A JP5620417B2 (ja) 2011-02-07 2012-02-07 アミノピラゾール誘導体を含む医薬

Publications (3)

Publication Number Publication Date
JP2012180344A JP2012180344A (ja) 2012-09-20
JP2012180344A5 true JP2012180344A5 (en:Method) 2014-10-02
JP5620417B2 JP5620417B2 (ja) 2014-11-05

Family

ID=47011846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012023811A Expired - Fee Related JP5620417B2 (ja) 2011-02-07 2012-02-07 アミノピラゾール誘導体を含む医薬

Country Status (1)

Country Link
JP (1) JP5620417B2 (en:Method)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3015953B1 (ja) 1998-10-06 2000-03-06 株式会社ワールド・ブリック れんが壁
CN104797710A (zh) 2012-09-27 2015-07-22 中外制药株式会社 Fgfr3融合基因和以其作为标靶的药物
CN103224479B (zh) * 2013-04-26 2014-10-15 温州大学 一种2-芳基苯并呋喃类化合物的合成方法
JP5681940B1 (ja) * 2013-07-31 2015-03-11 中外製薬株式会社 アミノピラゾール誘導体含有医薬品製剤
CA2927252C (en) * 2013-10-25 2021-09-28 Novartis Ag Ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
CA2929785C (en) * 2013-12-13 2018-02-13 F. Hoffmann-La Roche Ag Inhibitors of bruton's tyrosine kinase
WO2015086642A1 (en) 2013-12-13 2015-06-18 F. Hoffmann-La Roche Ag Inhibitors of bruton's tyrosine kinase
ES2756175T3 (es) * 2013-12-27 2020-04-27 Chugai Pharmaceutical Co Ltd Genes mutantes guardián de fgfr y fármacos que se dirigen a los mismos
US10703798B2 (en) 2014-03-31 2020-07-07 Debiopharm International Sa Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)
WO2016054483A1 (en) * 2014-10-03 2016-04-07 Novartis Ag Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
US9802917B2 (en) * 2015-03-25 2017-10-31 Novartis Ag Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
WO2016204261A1 (ja) * 2015-06-17 2016-12-22 中外製薬株式会社 アミノピラゾール誘導体
US10214515B2 (en) 2015-08-20 2019-02-26 Zhejiang Hisun Pharmaceutical Co., Ltd. Substituted pyrazoles as inhibitors of fibroblast growth factor receptor
CN110950848B (zh) * 2018-09-27 2024-03-26 徐诺药业 新型氨基吡唑类衍生物的合成与应用
US12180207B2 (en) 2018-12-19 2024-12-31 Array Biopharma Inc. Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kinases
JP2022515197A (ja) 2018-12-19 2022-02-17 アレイ バイオファーマ インコーポレイテッド がんを治療するためのｆｇｆｒ阻害剤としての７－（（３，５－ジメトキシフェニル）アミノ）キノキサリン誘導体
CN112358435B (zh) * 2019-10-12 2023-01-10 中国医学科学院医药生物技术研究所 取代芳并杂环类化合物、制备方法和抑制ulk1及抗肿瘤用途
CN117642400A (zh) * 2021-12-13 2024-03-01 上海和誉生物医药科技有限公司 一种fgfr4抑制剂酸式盐及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU765030B2 (en) * 1998-05-05 2003-09-04 F. Hoffmann-La Roche Ag Pyrazole derivatives as p-38 map kinase inhibitors
US6316466B1 (en) * 1998-05-05 2001-11-13 Syntex (U.S.A.) Llc Pyrazole derivatives P-38 MAP kinase inhibitors
BRPI0411825B8 (pt) * 2003-06-26 2021-05-25 Novartis Ag inibidores de p38 quinase a base de heterociclo de 5 elementos, seus processos de preparação e seus usos, bem como composição farmacêutica
CN102099335A (zh) * 2008-07-23 2011-06-15 弗·哈夫曼-拉罗切有限公司 杂环抗病毒化合物

Similar Documents

Publication Publication Date Title
JP2012180344A5 (en:Method)
IL261852A (en) Substituted imidazole based compounds for treatment of cancer
DK2900269T3 (en) COMBINATION OF REGORAFENIB AND ACETYLSALICYLIC ACID FOR TREATMENT OF COLORECTAL CANCER.
RU2016118753A (ru) Производные пиридилкетона, способ их получения и их фармацевтическое применение
JP2013535491A5 (en:Method)
JP2018520195A5 (en:Method)
JP2019537570A5 (en:Method)
RU2013106754A (ru) Производное фталазинонкетона, способ его получения и его фармацевтическое применение
PH12018550049A1 (en) Protein kinase inhibitor, preparation method and medical use thereof
JP2014512356A5 (en:Method)
JP2012520861A5 (en:Method)
JP2013520443A5 (en:Method)
JP2019522055A5 (en:Method)
JP2013507425A5 (en:Method)
RU2019114940A (ru) Лечение катаплексии
RU2013128448A (ru) Производные триазола в качестве ингибиторов сигнального пути wnt
JP2014513704A5 (en:Method)
JP2014534200A5 (en:Method)
JP2014512354A5 (en:Method)
CN115605479A (zh) 吡啶酮并嘧啶类衍生物、其制备方法及其在医药上的应用
JP2013529196A5 (en:Method)
JP2013544261A5 (en:Method)
RU2016130932A (ru) Производные хинолона как ингибиторы рецептора фактора роста фибробластов
JP2014530811A5 (en:Method)
JP2016531108A5 (en:Method)